In the entire cohort, six patients suffered from discontinuation of immunotherapy due to moderate or severe irAEs, including one Grade 3 (G3) fatigue, one G3 drug rash, one G3 immune‐related psoriasis, one Grade 2 (G2) increased alanine aminotransferase (ALT) and aspartate transaminase (AST), and two G2 pneumonitis. Here, GPT is linked to pneumonitis.